A breast cancer gene signature for indolent disease

PURPOSE: Early-stage hormone-receptor positive breast cancer is treated with endocrine therapy and the recommended duration of these treatments has increased over time. While endocrine therapy is considered less of a burden to patients compared to chemotherapy, long-term adherence may be low due to...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Breast Cancer Res Treat
Päätekijät: Delahaye, Leonie J. M. J., Drukker, Caroline A., Dreezen, Christa, Witteveen, Anke, Chan, Bob, Snel, Mireille, Beumer, Inès J., Bernards, Rene, Audeh, M. William, van’t Veer, Laura J., Glas, Annuska M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2017
Aiheet:
Epidemiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487706/
https://ncbi.nlm.nih.gov/pubmed/28451965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4262-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia